Moser, Elizabeth C <br/><br/>
Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.  [electronic resource] 

 -  Haematologica  Nov 2006 
 - 1481-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cohort Studies<br/>Cyclophosphamide--adverse effects<br/>Doxorubicin--adverse effects<br/>Europe--epidemiology<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasms, Second Primary--chemically induced<br/>Prednisone--adverse effects<br/>Registries<br/>Retrospective Studies<br/>Risk Factors<br/>Vincristine--adverse effects